Janux Therapeutics
JANX
JANX
155 hedge funds and large institutions have $1.87B invested in Janux Therapeutics in 2024 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 58 increasing their positions, 33 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
4.3% more ownership
Funds ownership: 81.95% → 86.26% (+4.3%)
8% less call options, than puts
Call options by funds: $4.12M | Put options by funds: $4.46M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
155
Holding in Top 10
2
Calls
$4.12M
Puts
$4.46M
Top Buyers
| 1 | +$65.5M | |
| 2 | +$61.6M | |
| 3 | +$42M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$30.4M |
| 5 |
BlackRock
New York
|
+$27.2M |
Top Sellers
| 1 | -$104M | |
| 2 | -$54.3M | |
| 3 | -$37.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$33.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$18.8M |